Physician profile
Larry Sears
NPI 1740395391
$4,086.15
in general payments reported to CMS, 2019-2025
45 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $858 · 2021: $711 · 2022: $647 · 2023: $619 · 2024: $237 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $905.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $877.03 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $247.00 | 2020-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $211.05 | 2020-2023 | Bexsero, Pediarix, Rotarix |
| Sanofi-Aventis U.S. LLC | $196.01 | 2020-2022 | |
| Pfizer INC. | $190.09 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.86 | 2021-2025 | Jardiance |
| Sunovion Pharmaceuticals INC. | $136.02 | 2019-2021 | |
| Amgen INC. | $113.84 | 2020-2023 | Repatha, Otezla |
| Ironshore Pharmaceuticals INC. | $91.38 | 2019-2023 | Jornay Pm |
| Mylan Specialty L.P. | $75.94 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $61.20 | 2019-2020 | Xyosted |
| Novartis Pharmaceuticals Corporation | $57.51 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $53.78 | 2019 | |
| Astellas Pharma US INC | $48.46 | 2023 | Veozah, Myrbetriq |
Show all 44 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Sears listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.